Mark Hughes

Mark Hughes began his career in clinical research at the Harvard School of Public Health and progressed into immunoassay research and development for Dade Behring’s former Clinical Assay division. He has held management positions in market research and business planning at the Ares-Serono Group and Gene-Trak Systems.

Mark has more than 30 years of experience in the clinical diagnostics industry and has been with EAC since 1997. He has broad experience in characterization of in vitro diagnostic (IVD) and non-IVD market and product segments. He also has done extensive work in technology assessments, market analysis, business strategies and due diligence.

Mark has worked on a wide range of assignments for major diagnostic, pharmaceutical and start-up biotechnology companies, as well as investment banks and venture capital firms. He is often quoted in many industry publications for his insights into the IVD industry.

Mark received his BS from the University of Massachusetts at Amherst and his MBA from Duke University.